Dr. Evi Giannakakou

Study Identifies Gene Linked to Chemotherapy Resistance in Prostate Cancer

March 10, 2026

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center.

Dr. Evi Giannakakou
Dr. Paraskevi Giannakakou
Englander Institute for Precision Medicine
Graduate School of Medical Sciences
Hematology/Medical Oncology
Research
News from WCM

Dr. Evi Giannakakou, Dr. Paraskevi Giannakakou, Englander Institute for Precision Medicine, Graduate School of Medical Sciences, Hematology/Medical Oncology, Research, News from WCM